Cargando…
ROCK2-Specific Inhibitor KD025 Suppresses Adipocyte Differentiation by Inhibiting Casein Kinase 2
KD025, a ROCK2 isoform-specific inhibitor, has an anti-adipogenic activity which is not mediated by ROCK2 inhibition. To identify the target, we searched binding targets of KD025 by using the KINOMEscan(TM) screening platform, and we identified casein kinase 2 (CK2) as a novel target. KD025 showed c...
Autores principales: | Tran, Nhu Nguyen Quynh, Chun, Kwang-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401933/ https://www.ncbi.nlm.nih.gov/pubmed/34443331 http://dx.doi.org/10.3390/molecules26164747 |
Ejemplares similares
-
Anti-adipogenic effects of KD025 (SLx-2119), a ROCK2-specific inhibitor, in 3T3-L1 cells
por: Diep, Duy Trong Vien, et al.
Publicado: (2018) -
Determination of KD025 (SLx-2119), a Selective ROCK2 Inhibitor, in Rat Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Pharmacokinetic Application
por: Yoon, Jin-Ha, et al.
Publicado: (2020) -
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
por: Jagasia, Madan, et al.
Publicado: (2021) -
KD025 (SLx-2119) suppresses adipogenesis at intermediate stage in human adipose-derived stem cells
por: Diep, Duy Trong Vien, et al.
Publicado: (2019) -
KD025, an anti-adipocyte differentiation drug, enhances the efficacy of conventional chemotherapeutic drugs in ABCG2-overexpressing leukemia cells
por: Jing, Wen, et al.
Publicado: (2020)